Key points are not available for this paper at this time.
Albumin levels could be used as an independent predictor of the risk of nonsurvivors in critically ill patients with COVID-19.
Li et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: